Data as of Oct 28, 2026.
BIOY vs XBI: Differences, Returns & Fees
BIOY and XBI are measured over different days, and XBI charges 0.35% to BIOY's 1.07%.
askIQ about this page
askIQ about BIOY and XBI
Net assets on Oct 27, 2026: $1.5m for GraniteShares YieldBOOST Biotech ETF and $10.3bn for State Street SPDR S&P Biotech ETF.
Pair scorecard
XBI costs 0.72 points a year less; XBI is far larger, $10.3bn against $1.5m.
| Measure | BIOY | XBI |
|---|---|---|
| Return | ||
| Total return, 1 year | not published | +41.2% |
| Cash paid, share of starting value, since May 5, 2026 | 25.2% | |
| Price change, since May 5, 2026 | fell 22.4% | |
| Latest payout, annualized | 60.6% | |
| Return of capital, issuer estimate | 96% of the Sep 22, 2026 payment | |
| Drawdown | ||
| Below its all-time high | 8.9%, high on Feb 8, 2021 | |
| Against its benchmark | ||
| What it tracks | Benchmark: Biotech, measured through XBI | Biotech |
| Against its benchmark, same days | behind by 14.3 pts | |
| Cost and size | ||
| Expense ratio | 1.07% | 0.35% |
| Net assets, as of Oct 27, 2026 | $1.5m | $10.3bn |
| Active share vs the S&P 500 | 98% | |
| Holdings | ||
| Holdings in common | 0% | |
| In the S&P 500, by weight | 13% | |
| Top ten holdings, share of the fund | 18% | |
Holdings in common uses holdings dated Jun 30, 2026 and Oct 27, 2026. Method
Risk and return
May 15, 2026 to Oct 23, 2026 · 23 weekly returnsXBI returned more: +14.5% to +2.2%. BIOY fell less at its worst: −5.8% to −12.9%.
Full scorecard
3 measures, with how each is measured Open ↓
| Measure | BIOY | XBI | Edge | How it is measured |
|---|---|---|---|---|
| Return | ||||
| Total return | +2.2% | +14.5% | XBI | Price change plus distributions, reinvested. |
| Price return | −21.6% | +14.4% | XBI | Price change alone, distributions left out. |
| Risk | ||||
| Max drawdown | −5.8% | −12.9% | BIOY | Deepest fall from a high to the low after it. |
Computed by ETFIQ from Tiingo daily prices and ETFIQ's distribution records, 23 weekly returns. Cash rate: the 13-week Treasury bill.
What they share
By the books each fund has filed, BIOY and XBI hold 0% of their money in the same securities at the same weight. Holdings dated Jun 30, 2026 and Oct 27, 2026.
half
0% in common
Only in one fund ↓
Side by side
BIOY and XBI on the fields both publish, as of Oct 28, 2026. Source: ETFIQ.
No client brief for this pair: ETFIQ prints no one-year total return for BIOY; the two funds' holdings are dated 119 days apart.
BIOY
Over the period from its first trade on May 5, 2026 to Oct 28, 2026, BIOY paid 25.2% of its starting value in cash distributions while its price fell 22.4%. With every distribution reinvested, the fund returned +3.5%. Biotech (XBI) returned +17.8% over the same days, so a holder was behind by 14.3 pts. At its price on Oct 28, 2026 the latest distribution annualizes to 60.6%, paid weekly. GraniteShares estimates that 96% of the distribution paid Sep 22, 2026 was a return of capital (its 19a-1 notice). That is a tax label, not a measure of erosion.
XBI
By weight, 13% of XBI's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 98%. The top ten holdings are 18% of the fund across 165 positions, as published by its issuer for Oct 27, 2026. Over the year to Oct 28, 2026 the fund returned +41.2% with distributions reinvested. It sits 8.9% below its all-time high of Feb 8, 2021.
Questions people ask
- Are BIOY and XBI in the same category?
- BIOY is an option-income ETF and XBI is a thematic ETF, so they do different jobs. The table compares what both publish: return, cost and holdings.
- Which is cheaper, BIOY or XBI?
- XBI is cheaper, by 0.72 percentage points a year. That is about $72 on $10,000 held for a year. Fees come from each fund's prospectus.
Links are sources, not endorsements. A comparison is not a recommendation.
How this is computed
Overlap adds up the smaller of the two weights for each security both funds hold.
Cite this pageCitation, APA and Markdown
ETFIQ, BIOY against XBI, data as of Oct 28, 2026. https://etfiq.com/compare/any/bioy-vs-xbi
ETFIQ. (Oct 28, 2026). BIOY against XBI. Retrieved from https://etfiq.com/compare/any/bioy-vs-xbi
[BIOY against XBI (ETFIQ, Oct 28, 2026)](https://etfiq.com/compare/any/bioy-vs-xbi)
Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.